RPG Life Sciences Limited

NSE: RPGLIFE · Unclassified

₹2,553.70-1.62%06 Nov 2026

Ask the data

Instant answers about RPG Life Sciences Limited — computed from its filings, no language model

Market cap₹3,979 cr

Current price₹2,553.70

High / Low₹3,089 / ₹1,744

P/E70.4

P/B5.79

Book value₹441.0

ROE8.2%

ROCE21.1%

Debt / equity0.03

Dividend yield1.00%

EPS (TTM)₹36.26

Face value₹8

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY26
Revenue	707.5
EBITDA	147.1
Operating margin	20.8%
Interest	0.9
Depreciation	21.5
Profit before tax	154.2
Tax	39.0
Net profit	115.2
EPS ₹	18.08
Operating cash flow	56.5
Capex	65.4
Dividend paid	39.7
Total assets	793.1
Equity	605.4

Quarterly performance

last 4 quarters · ₹ crore

	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	180.0	176.9	195.7	211.6
Operating profit	39.8	32.8	43.3	40.4
Operating margin	22.1%	18.6%	22.1%	19.1%
Other income	3.4	12.4	4.7	4.3
Interest	0.2	0.4	0.6	0.8
Depreciation	5.4	5.7	5.9	6.8
Profit before tax	29.1	40.2	41.5	37.0
Tax	7.0	10.3	10.7	8.8
Net profit	0.0	29.9	0.0	26.6
EPS ₹	13.38	18.08	18.60	17.07

Earlier results (standalone, Jun '08 – Sep '25)

₹ crore · from BSE, before the NSE XBRL filings begin

RPG Life Sciences Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 17 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†	FY20†	FY21†	FY22†	FY23†	FY24†	FY25†
Revenue	144.0	163.1	187.8	192.9	221.6	235.3	242.0	279.3	304.4	347.1	330.2	375.6	389.1	440.2	512.8	582.0	653.4
Operating profit	25.9	31.8	32.8	17.7	16.1	11.5	13.9	23.5	29.1	37.5	33.5	59.1	69.9	86.4	102.7	128.2	159.7
Operating margin	18.0%	19.5%	17.4%	9.2%	7.3%	4.9%	5.8%	8.4%	9.6%	10.8%	10.1%	15.7%	18.0%	19.6%	20.0%	22.0%	24.4%
Other income	—	—	—	—	1.8	2.6	—	0.8	0.6	1.0	0.9	0.7	0.9	3.0	4.8	7.2	12.7
Interest	8.6	8.1	5.8	5.8	7.4	2.6	2.7	2.5	2.6	3.8	4.0	1.8	0.8	0.5	0.3	0.5	0.6
Depreciation	9.4	9.2	9.5	10.2	9.9	10.6	11.4	10.2	11.8	14.3	15.3	16.4	16.5	15.7	15.5	17.1	21.4
Profit before tax	8.3	14.6	17.5	1.7	0.5	65.0	1.0	11.6	22.7	20.4	15.1	36.5	53.6	73.2	91.7	117.8	232.9
Tax	1.7	3.8	4.8	0.9	-3.9	11.6	0.0	0.0	2.2	6.9	4.2	7.4	13.6	21.7	24.0	30.2	49.6
Net profit	6.6	10.8	12.7	0.8	4.4	53.4	1.0	11.6	20.5	13.4	10.8	29.0	40.0	51.5	67.6	87.7	183.2

Quarters

showing latest 8 of 70 periods

	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†	SEP '19†	DEC '19†	MAR '20†	JUN '20†	SEP '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†	MAR '22†	JUN '22†	SEP '22†	DEC '22†	MAR '23†	JUN '23†	SEP '23†	DEC '23†	MAR '24†	JUN '24†	SEP '24†	DEC '24†	MAR '25†	JUN '25†	SEP '25†
Revenue	36.2	41.9	32.9	33.1	39.8	42.0	35.8	45.4	39.0	51.4	43.6	53.8	51.4	52.2	47.1	42.2	55.8	58.4	49.0	58.4	64.2	61.6	56.8	52.7	59.6	57.5	58.2	66.8	67.4	68.4	73.2	70.3	87.4	78.6	66.5	71.8	78.5	89.5	95.7	83.5	79.9	90.5	91.0	68.8	94.0	98.5	94.4	88.7	91.7	97.1	107.6	92.8	108.1	112.7	115.6	103.8	128.9	134.8	130.6	118.5	147.8	153.6	153.7	127.0	165.4	172.2	172.7	143.1	168.9	181.7
Operating profit	7.6	8.0	5.2	5.1	9.2	8.1	5.1	9.5	8.8	9.3	4.7	9.9	9.5	6.3	4.5	-2.6	6.5	4.7	-2.3	7.2	8.4	3.7	-2.9	2.2	3.5	-4.1	6.1	8.5	5.3	5.5	7.7	5.0	12.8	6.7	4.7	5.0	4.8	12.1	12.0	8.6	6.9	7.9	12.1	6.5	15.3	16.4	14.9	12.5	16.9	19.1	21.3	12.7	22.9	25.8	24.1	13.5	27.8	29.7	29.2	15.9	32.2	37.3	37.9	20.7	39.1	45.9	49.2	25.5	35.5	39.0
Operating margin	21.0%	19.1%	15.9%	15.5%	23.0%	19.2%	14.3%	20.9%	22.6%	18.1%	10.8%	18.5%	18.5%	12.0%	9.6%	-6.3%	11.6%	8.0%	-4.7%	12.4%	13.1%	6.1%	-5.1%	4.1%	5.8%	-7.2%	10.5%	12.7%	7.9%	8.0%	10.5%	7.1%	14.6%	8.5%	7.0%	7.0%	6.1%	13.5%	12.6%	10.3%	8.7%	8.7%	13.3%	9.5%	16.3%	16.7%	15.8%	14.1%	18.4%	19.7%	19.8%	13.6%	21.2%	22.9%	20.9%	13.0%	21.6%	22.1%	22.4%	13.4%	21.8%	24.3%	24.7%	16.3%	23.6%	26.7%	28.5%	17.8%	21.0%	21.5%
Other income	0.4	0.0	—	0.0	0.0	0.0	—	—	0.0	0.0	—	—	0.0	—	—	0.1	0.4	-0.0	0.5	0.9	0.8	0.8	0.5	0.4	0.3	0.3	0.5	—	0.3	0.5	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.5	0.3	0.4	0.1	0.0	0.4	0.2	0.1	0.0	0.4	0.5	0.0	0.1	0.3	0.4	0.7	0.6	1.3	1.2	1.2	0.5	1.8	1.8	1.8	1.9	1.6	2.4	1.9	3.3	5.1	5.2	4.5
Interest	2.2	2.1	2.2	2.0	2.1	2.1	2.1	1.9	1.5	1.5	1.4	1.5	1.4	1.5	1.7	1.3	1.7	1.7	2.0	2.1	1.6	0.3	0.3	0.4	0.4	0.7	0.9	0.7	0.9	0.8	0.6	0.2	0.4	0.2	1.0	1.1	1.0	1.1	0.9	0.8	1.0	1.1	1.0	0.9	0.7	0.4	0.4	0.3	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1
Depreciation	2.2	2.4	2.4	2.4	2.4	2.3	2.3	2.2	2.3	2.4	2.4	2.5	2.5	2.6	2.6	2.6	2.4	2.4	2.6	2.5	2.5	2.6	2.7	2.7	2.3	3.0	3.1	3.0	2.5	2.6	2.5	2.5	2.7	2.4	3.3	3.5	3.5	3.6	3.6	3.7	3.7	3.8	3.9	3.9	3.9	4.2	4.2	4.1	4.2	4.2	4.2	3.9	4.0	4.0	3.9	3.8	3.8	3.9	3.9	3.9	4.2	4.2	4.1	4.5	5.3	5.3	5.5	5.4	5.1	5.2
Profit before tax	3.6	3.5	0.6	0.6	4.7	3.7	0.7	5.4	5.0	5.5	0.9	6.0	5.6	2.2	0.3	-6.4	2.9	0.5	-6.3	3.5	69.4	1.7	-5.4	-0.7	1.1	-7.5	2.7	4.7	2.1	2.6	4.7	2.2	9.9	11.7	0.6	0.6	0.5	7.5	8.0	4.4	2.6	3.1	7.2	2.1	10.9	12.0	10.4	3.1	12.8	14.7	17.1	8.9	19.3	22.4	20.6	10.9	25.1	27.0	25.7	13.8	29.8	34.8	35.5	17.7	36.0	15.1	46.9	134.9	35.4	49.5
Tax	0.7	0.5	0.2	0.3	1.0	0.9	0.2	1.6	1.4	1.6	0.1	1.7	1.6	0.2	-0.2	-0.7	0.1	0.2	-0.3	-3.9	14.7	-0.5	-2.4	-0.1	-0.1	-0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.0	1.2	2.5	3.1	0.8	0.9	2.0	0.6	2.5	2.3	2.5	0.2	3.8	3.6	4.2	2.0	5.7	6.6	6.0	3.4	6.9	7.0	6.6	3.5	7.7	8.9	9.1	4.5	9.2	10.9	12.0	17.6	9.1	12.6
Net profit	2.9	3.0	0.4	0.4	3.8	2.8	0.5	3.7	3.7	3.9	0.8	4.3	4.0	2.1	0.5	-5.7	2.8	0.3	-6.1	7.4	54.7	2.2	-3.0	-0.5	1.2	-7.4	2.5	4.7	2.1	2.6	4.7	2.2	9.9	10.2	0.6	-0.2	0.4	6.3	5.5	1.2	1.8	2.2	5.3	1.5	8.3	9.8	7.9	3.0	9.1	11.2	12.9	6.9	13.6	15.8	14.6	7.5	18.2	20.0	19.1	10.3	22.1	25.9	26.5	13.2	26.8	4.2	34.9	117.3	26.3	36.9
EPS ₹	2.00	2.07	0.27	0.25	2.27	1.95	0.35	2.60	2.43	2.60	0.49	2.61	2.43	1.25	0.28	-3.44	1.69	0.18	-3.68	4.48	33.07	1.36	-1.83	-0.31	0.70	-4.47	1.53	3.04	1.29	1.55	2.82	1.36	5.97	6.20	0.33	-0.13	0.26	3.82	3.30	0.76	1.11	1.31	3.19	0.93	5.05	5.91	4.78	1.80	5.48	6.74	7.78	4.18	8.21	9.52	8.85	4.55	11.01	12.08	11.56	6.26	13.36	15.64	16.00	8.01	16.18	2.54	21.12	0.00	0.00	0.00
Revenue YoY	—	—	—	—	10.2%	0.3%	8.7%	37.4%	-2.0%	22.3%	21.8%	18.4%	31.7%	1.7%	8.0%	-21.5%	8.6%	11.8%	4.1%	38.4%	15.0%	5.4%	15.9%	-9.7%	-7.2%	-6.7%	2.5%	26.6%	13.2%	19.0%	25.7%	5.3%	29.6%	14.9%	-9.1%	2.2%	-10.2%	13.9%	43.8%	16.2%	1.8%	1.1%	-4.9%	-17.6%	17.7%	8.8%	3.7%	28.9%	-2.5%	-1.4%	14.0%	4.6%	18.0%	16.0%	7.4%	11.9%	19.2%	19.7%	13.0%	14.2%	14.6%	13.9%	17.7%	7.2%	11.9%	12.1%	12.4%	12.7%	2.1%	5.5%
Profit YoY	—	—	—	—	30.2%	-6.0%	30.8%	938.9%	-2.1%	39.6%	58.8%	15.5%	9.3%	-47.1%	-43.2%	-231.7%	-30.4%	-85.0%	-1423.9%	—	1860.2%	622.6%	—	-106.9%	-97.9%	-429.9%	—	—	84.5%	—	84.6%	-52.1%	361.2%	300.4%	-88.2%	-109.3%	-95.6%	-38.4%	892.7%	—	325.6%	-65.8%	-3.3%	23.2%	356.3%	352.3%	49.8%	93.5%	8.5%	14.1%	62.7%	132.2%	49.9%	41.3%	13.7%	8.7%	34.1%	26.8%	30.6%	37.6%	21.4%	29.5%	38.5%	27.9%	21.1%	-83.8%	32.0%	786.3%	-1.8%	777.4%

Returns & margins

trailing-twelve-month, per quarter

	SEP '26
ROE	8.2%
ROCE	21.1%
Net margin	7.4%
EBITDA margin	20.5%
Debt / equity	0.03
Interest coverage	71.06
Asset turnover	0.68

Balance sheet

equity vs borrowings over time · ₹ crore

	MAR '26	SEP '26
Share capital	13.2	13.2
Other equity / reserves	592.1	674.0
Total equity	605.4	687.2
Borrowings	20.0	22.3
Current liabilities	160.5	229.2
Non-current liabilities	27.2	20.7
Total assets	793.1	1,116.4
Property, plant & equipment	191.7	350.5
Capital work-in-progress	20.0	20.4
Investments	84.3	164.8
Inventories	123.8	173.4
Receivables	116.7	141.4
Cash & equivalents	150.5	110.5

Cash flow

annual · ₹ crore · line = free cash flow

	FY26
Cash from operations	56.5
Cash from investing	85.8
Cash from financing	-20.6
Capex	65.4
Free cash flow	-8.9
Dividends paid	39.7

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹350.5 cr31%

CWIP

₹20.4 cr2%

Investments

₹164.8 cr15%

Inventories

₹173.4 cr16%

Receivables

₹141.4 cr13%

Cash & equivalents

₹110.5 cr10%

Other assets

₹155.3 cr14%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
RPG Life Sciences Limited	3,979	2,553.70	70.4	5.79	8.2%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-11.7%

6 months+2.5%

1 year+4.5%

3Y CAGR+19.7%

5Y CAGR+29.9%

10Y CAGR+18.6%

50-day avg₹2,771.10

200-day avg₹2,381.76

RSI (14)35

FAQs

What is the share price of RPG Life Sciences Limited?

RPG Life Sciences Limited (RPGLIFE) closed at ₹2,553.70 on NSE on 06 Nov 2026.

What is the market cap of RPG Life Sciences Limited?

₹3,979 crore at the latest close.

What is the P/E ratio of RPG Life Sciences Limited?

70.4, on trailing-twelve-month earnings from its filings.

How fast is RPG Life Sciences Limited growing?

Not enough filed history yet to measure RPG Life Sciences Limited's growth.

How profitable is RPG Life Sciences Limited?

On a trailing-twelve-month basis return on equity is 8.2%, return on capital employed 21.1%, operating margin 20.5%, net margin 7.4%.

How much debt does RPG Life Sciences Limited have?

RPG Life Sciences Limited is debt-free: debt to equity is 0.03 with borrowings of ₹22 cr against cash of ₹111 cr (balance sheet of 2026-09-30). Operating profit covers interest 71.1 times.

Financials parsed from RPG Life Sciences Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '25, annual from FY26, balance sheet from Mar '26. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.